1h Free Analyst Time
Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Fortress Biotech Inc (Fortress Biotech), formerly Coronado Biosciences Inc, identifies, acquires, develops, and commercializes marketed pharmaceuticals and development-stage pharmaceutical product candidates. The company provides business, scientific, regulatory, and legal support for advancing the products or product candidates of its partner firms. It is a marketing partner for various branded drugs indicated for the treatment of radiation dermatitis, severe acne, athlete’s foot, inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and other skin infections. Fortress Biotech is headquartered in New York, the US.Fortress Biotech Inc Key Recent Developments
Dec 19, 2022: Fortress Biotech Appoints Lucy Lu, M.D., to its Board of DirectorsNov 14, 2022: Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Oct 03, 2022: Urica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer
Sep 08, 2022: Fortress Biotech to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company- Fortress Biotech Inc - Key Facts
- Fortress Biotech Inc - Key Employees
- Fortress Biotech Inc - Key Employee Biographies
- Fortress Biotech Inc - Major Products and Services
- Fortress Biotech Inc - History
- Fortress Biotech Inc - Company Statement
- Fortress Biotech Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Fortress Biotech Inc - Business Description
- Business Segment: Dermatology Product Sales
- Overview
- Performance
- Business Segment: Pharmaceutical and Biotechnology Product Development
- Overview
- Performance
- R&D Overview
- Fortress Biotech Inc - SWOT Analysis
- SWOT Analysis - Overview
- Fortress Biotech Inc - Strengths
- Fortress Biotech Inc - Weaknesses
- Fortress Biotech Inc - Opportunities
- Fortress Biotech Inc - Threats
- Fortress Biotech Inc - Key Competitors
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Fortress Biotech Inc, Recent Deals Summary
- Dec 19, 2022: Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
- Nov 14, 2022: Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
- Oct 03, 2022: Urica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer
- Sep 08, 2022: Fortress Biotech to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
- Aug 12, 2022: Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
- Aug 11, 2022: Mustang Bio Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
- Aug 11, 2022: Fortress Biotech Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
- Aug 09, 2022: Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
- Jul 22, 2022: Fortress Biotech Appoints David Jin as Chief Financial Officer
- Jun 16, 2022: Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Locally Advanced Cutaneous Squamous Cell Carcinoma
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- Fortress Biotech Inc, Key Facts
- Fortress Biotech Inc, Key Employees
- Fortress Biotech Inc, Key Employee Biographies
- Fortress Biotech Inc, Major Products and Services
- Fortress Biotech Inc, History
- Fortress Biotech Inc, Other Locations
- Fortress Biotech Inc, Subsidiaries
- Fortress Biotech Inc, Key Competitors
- Fortress Biotech Inc, Annual Ratios
- Fortress Biotech Inc, Interim Ratios
- Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Fortress Biotech Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- Fortress Biotech Inc, Performance Chart (2017 - 2021)
- Fortress Biotech Inc, Ratio Charts
- Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023
Companies Mentioned
A selection of companies mentioned in this report includes:
- Rocket Pharmaceuticals Inc
- Five Prime Therapeutics Inc
- Exicure Inc
- Eledon Pharmaceuticals Inc
- CoImmune Inc
- Five Prime Therapeutics Inc
- Exicure Inc
- Phio Pharmaceuticals Corp
- CoImmune Inc
- Rocket Pharmaceuticals Inc
- Eledon Pharmaceuticals Inc